World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
Dr. Chokri Ben Lamine, hematologist at King Faisal Specialist Hospital & Research Centre (KFSHRC), recently shared an exciting update on X:
“Historic First: Dr. Hazzaa Alzahrani (Adult Hematologist, KFSHRC) with Dr. Broering (Liver Transplant Team) performed the world’s first liver transplant for plasminogen deficiency, restoring plasminogen production and fibrinolysis successfully.Plasminogen Deficiency: Key Review
Definition: Rare AR (PLG mut) → ↓plasminogen → ↓fibrinolysis → fibrin-rich pseudomembranes (ligneous conjunctivitis, gingivitis, RT/GU obstruction).
Types:
Type I: ↓ antigen & activity
•Type II: nl antigen, ↓ activity
Clinical: Ligneous conjunctivitis (80%), gingivitis, RT/GU obstruction, hydrocephalus.
Diagnosis:
•↓ Plasminogen activity (functional assay)
•↓ Antigen (ELISA)
•Genetic testing
Management:
Supportive:
•Lubricants, surgical removal + fibrinolytics
Replacement Therapy:
•FFP 10–15 mL/kg q2–3w
•RYPLAZIM: 6.6 mg/kg q2d x6, then weekly FDA
Topical fibrinolytics: tPA, urokinase
Adjuncts: Avoid trauma, treat infections promptly
Experimental: Gene therapy & recombinant plasminogen trials
Complications: Airway obstruction, vision loss, renal involvement (rare)
Pearls:
•Consider in recurrent ligneous conjunctivitis
•Monitor plasminogen levels
•Early replacement prevents complications
References:
•FDA RYPLAZIM
•Schuster V et al. Haemophilia. 2000;6(3):162-172 PubMed
•Tefs K et al. Blood. 2006;107(12):4823-4830 DOI.”
Find the latest updates on Hemostasis Today.
-
Jul 13, 2025, 15:33ISTH Now Accepting Applications for SSC Leadership Roles
-
Jul 13, 2025, 15:32Last Chance to Apply: EHA Preceptorship on Precision Hematology in Germany!
-
Jul 11, 2025, 19:14ISTH 2025 for Cardiac Surgery: LEX-211 (FARES-II) Trial Shows Promising Results
-
Jul 11, 2025, 16:48GPAS 2025: Shaping the Future of Bleeding Disorder Care
-
Jul 10, 2025, 11:23HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
-
Jul 13, 2025, 18:182025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
-
Jul 13, 2025, 17:57Preventing VTE in Cancer, Maintaining Low Bleeding Risk: Reduced-Dose Apixaban
-
Jul 13, 2025, 17:172024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
-
Jul 13, 2025, 16:483-Factor Prediction Tool Targets Inactivity After Stroke to Prevent Recurrent Heart Events
-
Jul 12, 2025, 16:21Richard Buka։ Evolution’s Imprint on Blood, Natural Selection Shaping Today’s Hematologic Disorders
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025